Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832177 · ClinicalTrials.gov registry record

Outreach Core Activities

A clinical trial of Cancer Education and Spanish Language Cancer Education, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
1,200
Enrollment target
2
Study locations

NCT05832177 is a study of Cancer Education and Spanish Language Cancer Education that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 1,200 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832177, a study of Cancer Education and Spanish Language Cancer Education, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
1,200 participants
Enrollment target
2
Study locations

Study Summary

The Outreach Core (OC) of the Ponce Health Sciences University-Moffitt Cancer Center (PHSU-MCC) Partnership provides community outreach and education to improve cancer screening behaviors in our catchment area populations. The overall goal of the OC is to increase community cancer awareness, community engagement, and participation in cancer research and outreach in our catchment areas. Working closely with other Partnership cores and investigators, the team proposes to elevate and expand its activities to facilitate reciprocal communication between community members and partnership researchers through OC educational activities, training opportunities, supporting participant recruitment efforts, and incorporating the Community Advisory Panel (CAP) feedback on partnership research projects. Together with community members and Partnership researchers, the OC will increase cancer awareness, community engagement, and participation in cancer research in communities served by MCC (in FL) and PHSU (in PR) through the following three Specific Aims: Aim 1: To develop, deliver, and disseminate cancer education and outreach activities to our catchment area populations. The team will deliver cancer education to communities in PR and FL using evidence-based programs through multiple delivery strategies and reflecting partnership research priorities and topics of interest identified by community members. Aim 2: To enhance capacity for mutually beneficial research engagement to address cancer health priorities in our catchment areas. The team will facilitate communication between community members and partnership investigators (e.g., CAP Research Corner), support partnership research that is responsive to community needs (translational research), promote community participation in the partnership's research activities/projects, and train researchers and community members in community engagement principles. Aim 3: To expand the capacity to train community members as lay health pr

Interventions

  • BEHAVIORAL Cancer CientoUno (101) program
  • BEHAVIORAL Latinos y el cáncer/Hablemos de cáncer (Translation in English: Latinos and Cancer/Let's Talk About Cancer)
  • BEHAVIORAL ¡Salud! Serie de Charlas (Translation in English: Health! Talk Series)
  • BEHAVIORAL Community/Researcher Forum: El Puente (Translation in English: The Bridge).
  • BEHAVIORAL Lunch and Learn Updated Recommendations Series.

Study Locations (2)

Florida

  • Moffitt Cancer Center - Tampa

Other

  • Ponce Health Sciences University - Ponce

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2023-03-22
Est. Completion 2028-07

What the Registry Record Tells You About NCT05832177

The ClinicalTrials.gov registry entry for NCT05832177 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer Education appearing as the primary indexed condition, and to 5 interventions - of which Cancer CientoUno (101) program is the first listed.

NCT05832177 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Other.

Frequently Asked Questions

What is clinical trial NCT05832177 about?

NCT05832177 is a clinical study titled "Outreach Core Activities". The Outreach Core (OC) of the Ponce Health Sciences University-Moffitt Cancer Center (PHSU-MCC) Partnership provides community outreach and education to improve cancer screening behaviors in our catchment area populations. The overall goal of the OC is to increase community cancer awareness, communi...

What is the current status of trial NCT05832177?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2023-03-22. Estimated completion is 2028-07.

What conditions does trial NCT05832177 study?

This clinical trial studies the following conditions: Cancer Education, Spanish Language Cancer Education.

What interventions are being tested in trial NCT05832177?

The interventions under investigation include: Cancer CientoUno (101) program (BEHAVIORAL), Latinos y el cáncer/Hablemos de cáncer (Translation in English: Latinos and Cancer/Let's Talk About Cancer) (BEHAVIORAL), ¡Salud! Serie de Charlas (Translation in English: Health! Talk Series) (BEHAVIORAL), Community/Researcher Forum: El Puente (Translation in English: The Bridge). (BEHAVIORAL), Lunch and Learn Updated Recommendations Series. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05832177?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05832177 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.